Moreover, Cox regression analysis indicated that CASP4 expression was independently associated with tumor grade, age, histological type, 1p/19q co-deletion, IDH status, and primary treatment outcomes, indicating that it is related to glioma progression. Here, CASP4 is linked to central nervous system cancer.